Literature DB >> 24009441

Anthrax of the lower eyelid.

Ugur Koçer1, Hasan Mete Aksoy, Yigit Özer Tiftikcioglu, Berna Aksoy.   

Abstract

Because cutaneous anthrax, caused by Bacillus anthracis, is rare in developed countries, sporadic cases of anthrax may easily be overlooked because the diagnosis is often difficult to make. Lower eyelid involvement of anthrax is rare in clinical practice. A 40-year-old woman with a history of contact with animals was evaluated and treated for a left lower eyelid lesion with a black eschar on it. A diagnosis of cutaneous anthrax had been made and intravenous penicillin had been given by the department of infectious diseases before plastic surgery consultation. Any kind of surgical intervention was delayed for three months. The lesion healed secondarily and the resulting scar did not result in ectropion of the lower eyelid. Delaying surgery is preferred because it is a safer approach when dealing with anthrax involving the lower eyelid, and secondary healing does not always result in deformity compromising function.

Entities:  

Keywords:  Anthrax; Delayed surgery; Lower eyelid

Year:  2003        PMID: 24009441      PMCID: PMC3760752          DOI: 10.1177/229255030301100401

Source DB:  PubMed          Journal:  Can J Plast Surg        ISSN: 1195-2199


  5 in total

1.  Cutaneous anthrax leading to corneal scarring from cicatricial ectropion.

Authors:  D Yorston; A Foster
Journal:  Br J Ophthalmol       Date:  1989-10       Impact factor: 4.638

2.  [Suspected palpebral anthrax in children. (Apropos of 3 cases)].

Authors:  A Daboué; W Traoré; B Nacro; A Sawadogo
Journal:  Bull Soc Pathol Exot       Date:  2000-02

3.  [Late aspects of palpebral anthrax (author's transl)].

Authors:  M Chovet; M Ducam; A D Negrel; A de la Panouse
Journal:  Med Trop (Mars)       Date:  1979 Jan-Feb

4.  Anthrax of the eyelid.

Authors:  N A Barnard
Journal:  Ophthalmic Physiol Opt       Date:  1990-07       Impact factor: 3.117

5.  Anthrax of the eyelids.

Authors:  A Amraoui; K F Tabbara; K Zaghloul
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.